Geron | GERN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Amgen USD 13.99B 1.95B 2026-06
Bio Techne USD 264.71M 54.89M 2026-06
Cassava Sciences USD 86.57M 8.93M 2026-03
Cytokinetics USD 255.27M 125.43M 2026-06
Exelixis USD 281.45M 55.3M 2026-06
Genmab DKK 1.5B 18M 2026-06
Geron USD 62.64M 6.25M 2026-06
Gilead Sciences USD 7.63B 64M 2026-03
Incyte USD 3.98B 33.45M 2026-06
MacroGenics USD 113.91M 47.39M 2026-06
Novartis USD 7.62B 739M 2026-06
Novavax USD 191.46M 36.9M 2026-06